Allen is an inventor, geologist, and tech visionary that created several large companies including a billion-dollar technology platform which revolutionized software in the oil and gas industry. He is the Founder, Advisor, and former CEO/Chairman of Enverus (formerly Drillinginfo) and Co-founder of Vecta Oil & Gas, Ltd, formed around his patents in the field of multicomponent seismology. Vecta and its spinoff investments have discovered over 100 million barrels of oil equivalent in proven reserves to date. Drillinginfo was the most quickly and widely adopted software platform in the history of the oil and gas industry. Today, nearly 10,000 companies comprising nearly 90% of US oil and gas capex subscribe to Drillinginfo’s SaaS offerings. Allen served as Executive Chairman of the Board for 20 years and CEO for 14 years. Prior to founding Drillinginfo, he was an independent oil and gas producer, founding 3 successful oil and gas companies.

Allen is the immediate past Chairman of the Texas Independent Producers and Royalty Owners (TIPRO), past Texas Chair and National Board member of the DOE’s Petroleum Technology Transfer Council (PTTC), and member of the Development Board of the University of Texas at El Paso (UTEP), Advisory Board of UTEP’s College of Science, and several other nonprofit organizations. He was selected as a Top 20 Energy Innovator by Hart Energy in 2019, as UTEP’s Distinguished Alumni in 2017, Austin Business Journal’s Large Company CEO of the Year in 2014, Top 7 Upstream Influencers in 2014, Texas Monthly’s Texas Outstanding Geoscientist in 2012, E&Y’s Entrepreneur of the Year in Central Texas in 2012, and Top 100 Energy Influencers in 2011.

Fahim has built multiple healthcare technology companies over the past 20 years to save lives and create healthcare innovation. He started inGeneUs with a dream to assemble a consortium of scientists, physicians, and healthcare leaders to develop novel biomedical technologies and solve some of our biggest global healthcare challenges. As the company started growing quickly and impacting thousands of lives in behavioral health, the dream became contagious; InGeneUs has evolved into a biotech conglomerate of 6 divisions led by experienced healthcare leaders, each pioneering different facets of genetic innovation. As a result of the combined passion to save lives and bring innovation, inGeneUs has become a pioneer in Behavioral Genetics, developing proprietary genetic diagnostics and epigenetic solutions for behavioral disease.

Earlier in his career, Fahim was a management and technology consultant serving Fortune 500 companies in New York City and Los Angeles. Fahim attended West Point and Cornell University.

Rehan Jalali has been living an inspiring life; he has trained, motivated, and advised some of the most accomplished actors, athletes, artists, and performers in the world and helped them perform at peak human levels. He has proven this repeatedly. This is why gold-medal Olympic performers seek his guidance and why Hollywood goes to Rehan to build superhero bodies for blockbuster movie productions. This is on top of his own personal accomplishments which include being a natural bodybuilder who has appeared on ESPN and CBS and having held numerous bodybuilding titles including Mr. Texas and the Ironman Naturally Bodybuilding Champion. Rehan’s quest for perfection in human performance has brought him to getting to the essence of human biology through genetics. He is a pioneer in combining genetics testing with personalized nutrition and world-class performance. Rehan has been building this paradigm since the late 1990s and the healthcare industry is finally starting to catch on with his transformative ideas that can improve millions of lives.

Rehan is a nationally recognized Certified Sports Nutritionist (C.S.N.) who has developed over 100 cutting edge products for the dietary supplement industry. His clients include Oscar® winning actors, Emmy® award winning TV stars, and Grammy® winning musicians. He has developed cutting-edge customized nutrition and supplementation programs for actors getting ready for movie roles, musicians preparing for videos, and celebrities peaking for appearances including award shows. His goal is to Change the World One Body at a Time.
Rehan also has over 250 nationally and internationally published articles on nutrition and supplementation. Long considered an authority on sports nutrition, Rehan is the author of The Six Pack Diet Plan, The Sports Supplement Buyers Guide, The Ultimate Performance Guide to Fitness Success and co-author of The Bodybuilding Supplement Guide. He is host of the supplement segment on the weekly TV series “The Art of Building Bodies.” Rehan is also a member of the American Medical Writers Association.

Rodger brings 25+ years of experience as a senior architect, engineer, and managing consultant in the healthcare and life sciences industry specializing in big data and data science initiatives including enterprise data warehousing, AI and machine learning pipelines, cloud adoption, and advanced analytics such as identification / stratification, and predictive modeling.

Providing thought leadership, execution, and results in all engagements, he is a technologist with a propensity towards enabling organizations to remove barriers and thrive in a data driven ecosystem, including cloud adoption, distributed computing, big data, and data sciences. He has harnessed the power of digital petabytes into valuable usable & actionable collateral for the likes of WebMD, Blue Cross Blue Shield, and Alianz Life..

His passion is to develop transformative technologies in healthcare by staying on the cutting edge. He has been responsible for the development of healthcare solutions with tools such as the AWS Enterprise Data Hub Catalog (Lambda, S3, DynamoDB, Snowflake), Airflow HA, Terraform, Python, SQL, and Salesforce.

By merging compassion with data, Rodger is the digital backbone of our mission to save and improve lives with groundbreaking genetic technologies.

Jay has 30-year experience leading high growth healthcare services businesses. He has successfully led operating teams to double and triple the size of these businesses with the most recent one exceeding $1B revenues annually within 5 years through operational excellence and change acceleration.

He has expertise in leading globally distributed service delivery teams ranging from 150 to 2,500 associates. He has held senior executive leadership positions at both privately and publicly held companies such as GE Healthcare, Allscripts, Orion Health, and Aetna. Most recently, he served as Executive Vice President, Operations and Chief Transformation Officer at TRIMEDX.

Jay earned a master’s degree in Electrical Engineering from Alfred University and a bachelor’s degree in Electrical Engineering from Cornell University.

As a strong supporter of public service and US diplomacy, Mehmood has served in the executive branch of the US government as a senior advisor for strategy for our nation’s key international media networks. Previously he has been a partner in a residential real estate development fund, a private equity firm focused on SMEs in technology and healthcare management, and an international PE advisory firm focused on Turkey, MENA and SE Asia. As part of these roles, he has taken active management positions as an executive in companies in which his firms are invested or advising.

After completing his MBA from Harvard Business School, Mehmood spent five years at America Online as an operations strategy and marketing executive. At AOL, he managed over four- hundred million dollars of promotional inventory each year across America Online’s media network, and served as the business lead maximizing the impact and profitability of AOL’s famed ‘Welcome Screen’, then the highest-traffic page on the internet.

After completing his BA in Economics from George Washington University, as the recipient of a Presidential Honor Scholarship, Mehmood’s first business was launching, growing and eventually selling an international children’s educational media distribution and production company.

Mehmood is appointed to the Board of Visitors of George Mason University by the current Governor of Virginia and previously served on the Board of Virginia Tech by appointment of the prior Governor. He is a Fellow of UVA’s Sorensen Institute Political Leadership Program and has served two terms as a Member of the Consumer Protection Commission of Fairfax County, Virginia.

Justin Mars is a visionary in the recovery industry and an inspiring leader on our executive team. He has devoted his career to working with thousands of people in recovery. He is literally working to save lives every day, including mitigating suicide ideation as a Certified National Interventionalist with a QPR Suicide Prevention Master’s Training License. Mr. Mars receives fan mail regularly from clients and their families who thank him for saving their lives because they know how much he cares. He utilizes his 15 years of expertise in recovery, treatment, management, and leadership to set the standards of excellence in Symmetry.

He has managed a large network of treatment centers and is a leader in several recovery organizations. Mr. Mars has personally developed counseling, therapy, and community-based programs to improve lives for thousands of people suffering from substance abuse. He also provides business leadership and compliance advisory to recovery networks and organizations across California and the country. Mr. Mars attended University of Texas at Austin.

Oscar is an experienced financial executive with extensive and multi-faceted experience in IPOs and M&A. Oscar personally managed IPOs for 2 large companies, one of them a being a multi-billion dollar public offering. He started his early career at Accenture as a management consultant and got his first experience there, managing large teams and divisions. After this, he got his MBA from Harvard Business School and then started his career in finance at JP Morgan in investment banking. Following several years on Wall Street, he became the CFO for two public companies including Foresight Energy which had over $1 billion in revenue prior to its IPO that was managed by Oscar. Most recently, Oscar was the Chief Operating Officer of Equifax Workforce Solutions, which is a $1 billion division of Equifax where he led a team of 1,650 executives and employees successfully.

Oscar has spent most of his career playing C-level executive roles involved in driving the success of many large companies with an emphasis on financial planning and strategy. He has also worked around the world in multiple countries and has an international perspective in growing companies with a worldwide reach. Oscar comes to inGeneUs with the goal of expanding a company that can bring significant innovation to healthcare and help improve the lives of millions of people around the world.

Dr. Ali Raza is a physician entrepreneur that brings a unique skillset to inGeneUs as a result of his eclectic experience in engineering, finance, technology, and medicine. He started his college education at the age of 15, enrolling at Cornell University in electrical engineering and then receiving his master’s in electrical engineering from University of Pennsylvania. Dr. Raza started his career in corporate finance on Wall Street at JP Morgan and Credit Suisse for 7 years. He then shifted to development of technology business solutions for Pfizer and AOL. He shifted again as a pioneer of early telemedicine development in the late 1990s in New York City. Still not finding fulfillment, he ultimately decided to become a physician on the other side of the world at University of Sydney Medical School and a Fellow of the Royal College of General Practitioners. To put his medical degree to work, he built a premier integrative health care center in in Sydney, Australia called Ultimo Medical, to help improve the lives of thousands of patients.

After seeing the potential at inGeneUs and what his experience could bring to our company, Dr. Raza felt he could help build inGeneUs into a transformative healthcare company, so he moved back to the United States to achieve this objective while continuing to remotely advise and grow his medical team in Sydney. Through his diverse and circuitous journey, Dr. Raza has gained a range that is rare in healthcare. He has now emerged as a clinical pioneer for inGeneUs in merging integrative care with groundbreaking biomedical technology solutions for transformative change.

In addition to being one of the leading neurosurgeons of his generation, Dr. Sandhu was awarded Washingtonian Top Doctor for Neurosurgery in 2019 and is one of the strategic medical advisors in our company. Dr. Sandhu is an important advisor for the vision, groundbreaking research, and strategic growth of our company. He is a Professor of Neurological Surgery at Georgetown University Medical Center and Director of Spinal Surgery at Georgetown University Hospital. He owns several patents for his inventions in Neurological Surgery. Dr. Sandhu is recognized in Strathmore’s Who’s Who, Best Doctors, America’s Top Surgeons, and was awarded the Robert Kates Award for Outstanding Clinical and Research Work.

Dr. David Siwicki is a successful physician entrepreneur who founded two large national diagnostic healthcare companies while also practicing as a board-certified physician in addiction medicine. Furthermore, he is an industry pioneer in diagnostic testing having founded two of the largest diagnostic testing companies in the country. He was a founder of Dominion Diagnostics and served as President and Director since its founding in 1997. Dominion Diagnostics is an accredited national medical laboratory that provides drug monitoring solutions and actionable clinical information to improve patient care and treatment outcomes in addiction medicine. He was also Founder and President of National WorkSafe, a national provider of medical review and drug testing verification services for the transportation industry. He has over 30 years of experience in healthcare as a physician and businessman.

Dr. Siwicki sits on the Herbert W. Boyer School of Natural Sciences, Mathematics, and Computing’s Advisory Council at Saint Vincent College in Latrobe, Pennsylvania. Dr. Siwicki also serves on the Executive Council of iEurope Capital, a Private Equity Firm investing in Central & Eastern Europe. From 1990 through 2010 he was a practicing member of Kent Emergency Physicians, Inc. Dr. Siwicki is Board Certified by the American Board of Addiction Medicine and is a certified Medical Review Officer.

Kareem Washington, PhD, is Chairman of the Department of Human Genetics at Howard University College of Medicine. An expert in molecular and applied genetics, Dr. Washington has worked with Dr. Mitchell to develop high-throughput screening (HTS) and ribonucleic acid (RNA) trans-splicing molecules (RTM) optimization procedures. Dr. Mitchell, a preeminent biochemical geneticist and professor, leads the Splice Therapeutics RTM core laboratory which creates and develops RTMs for the treatment of inherited and acquired genetic diseases.

Dr. Washington serves on the steering committee for the Center for Hemoglobin Research in Minorities at Howard University and is on the advisory board for the NIH National Human Research Genome Institute Atlas of Human Malformation Syndromes. He has published numerous articles and conference papers, including in the journals for Human Gene Therapy Methods, MDPI’s Biology, Anticancer Research, Molecular Therapy, Retrovirology, and Molecular and Cellular Biochemistry.

Having discovered the genetic link to addiction over 30 years ago, Dr. Kenneth Blum is the worldwide pioneer of addiction genetics and created an entire industry within genetic science. Dr. Blum’s lifetime dedication to the genetics of addiction has placed him at the vanguard of both the academic development and practical application of science and solution. He has been the recipient of multiple achievement awards including Lifetime Achievement in Addiction Medicine (Holistic Institute on Addiction Studies), Marquis Who’s Who Lifetime Achievement Award, and Presidential Award for Scientific Excellence (National Council of Alcohol & Drug Abuse Counselors).

He coined the term “Reward Deficiency Syndrome,” which is now found in the Gates Scientific Dictionary and SAGE Encyclopedia. He has published over 650 abstracts, peer–reviewed articles and 17 books. He has honorary professorships in universities around the world for his extraordinary accomplishments. Dr. Blum is among only a small handful of world-renown experts in addiction and genetics, quoted in studies and medical journals around the world. We are honored to have him as a visionary on our team.

Allen is an inventor, geologist, and tech visionary that created several large companies including a billion-dollar technology platform which revolutionized software in the oil and gas industry. He is the Founder, Advisor, and former CEO/Chairman of Enverus (formerly Drillinginfo) and Co-founder of Vecta Oil & Gas, Ltd, formed around his patents in the field of multicomponent seismology. Vecta and its spinoff investments have discovered over 100 million barrels of oil equivalent in proven reserves to date. Drillinginfo was the most quickly and widely adopted software platform in the history of the oil and gas industry. Today, nearly 10,000 companies comprising nearly 90% of US oil and gas capex subscribe to Drillinginfo’s SaaS offerings. Allen served as Executive Chairman of the Board for 20 years and CEO for 14 years. Prior to founding Drillinginfo, he was an independent oil and gas producer, founding 3 successful oil and gas companies.

Allen is the immediate past Chairman of the Texas Independent Producers and Royalty Owners (TIPRO), past Texas Chair and National Board member of the DOE’s Petroleum Technology Transfer Council (PTTC), and member of the Development Board of the University of Texas at El Paso (UTEP), Advisory Board of UTEP’s College of Science, and several other nonprofit organizations. He was selected as a Top 20 Energy Innovator by Hart Energy in 2019, as UTEP’s Distinguished Alumni in 2017, Austin Business Journal’s Large Company CEO of the Year in 2014, Top 7 Upstream Influencers in 2014, Texas Monthly’s Texas Outstanding Geoscientist in 2012, E&Y’s Entrepreneur of the Year in Central Texas in 2012, and Top 100 Energy Influencers in 2011.

Richard is a pioneer in bridging the legal system with addiction genetics and recovery to help save many lives and provide significant efficiencies for the legal system. He has had a profound impact on many lives in addiction recovery. Richard serves as the Parliamentarian for the Texas Association of Addiction Professionals State Board. He also serves on the Public Policy Committee for the National Association of Alcohol and Drug Addiction Counselors. Richard’s extensive clinical background and keen understanding of the legal system combine to make PTM a recovery program unparalleled in the nation. He also has experience consulting with Civil and Criminal Justice attorneys, pharmaceutical companies, and philanthropic treatment entities. Richard has been an addictions counselor since 2013 and has been in the Healthcare and Mental Healthcare field for over 20 years. He has an extensive background in psychiatric pharmaceuticals, drug/civil/criminal court, recovery advocacy and motivational research. Richard is a graduate of the University of Missouri and a member of the American Society of Addiction Medicine.

Fahim has built multiple healthcare technology companies over the past 20 years to save lives and create healthcare innovation. He started inGeneUs with a dream to assemble a consortium of scientists, physicians, and healthcare leaders to develop novel biomedical technologies and solve some of our biggest global healthcare challenges. As the company started growing quickly and impacting thousands of lives in behavioral health, the dream became contagious; InGeneUs has evolved into a biotech conglomerate of 6 divisions led by experienced healthcare leaders, each pioneering different facets of genetic innovation. As a result of the combined passion to save lives and bring innovation, inGeneUs has become a pioneer in Behavioral Genetics, developing proprietary genetic diagnostics and epigenetic solutions for behavioral disease.

Earlier in his career, Fahim was a management and technology consultant serving Fortune 500 companies in New York City and Los Angeles. Fahim attended West Point and Cornell University.

Rehan Jalali has been living an inspiring life; he has trained, motivated, and advised some of the most accomplished actors, athletes, artists, and performers in the world and helped them perform at peak human levels. He has proven this repeatedly. This is why gold-medal Olympic performers seek his guidance and why Hollywood goes to Rehan to build superhero bodies for blockbuster movie productions. This is on top of his own personal accomplishments which include being a natural bodybuilder who has appeared on ESPN and CBS and having held numerous bodybuilding titles including Mr. Texas and the Ironman Naturally Bodybuilding Champion. Rehan’s quest for perfection in human performance has brought him to getting to the essence of human biology through genetics. He is a pioneer in combining genetics testing with personalized nutrition and world-class performance. Rehan has been building this paradigm since the late 1990s and the healthcare industry is finally starting to catch on with his transformative ideas that can improve millions of lives.

Rehan is a nationally recognized Certified Sports Nutritionist (C.S.N.) who has developed over 100 cutting edge products for the dietary supplement industry. His clients include Oscar® winning actors, Emmy® award winning TV stars, and Grammy® winning musicians. He has developed cutting-edge customized nutrition and supplementation programs for actors getting ready for movie roles, musicians preparing for videos, and celebrities peaking for appearances including award shows. His goal is to Change the World One Body at a Time.

Rehan also has over 250 nationally and internationally published articles on nutrition and supplementation. Long considered an authority on sports nutrition, Rehan is the author of The Six Pack Diet Plan, The Sports Supplement Buyers Guide, The Ultimate Performance Guide to Fitness Success and co-author of The Bodybuilding Supplement Guide. He is host of the supplement segment on the weekly TV series “The Art of Building Bodies.” Rehan is also a member of the American Medical Writers Association.

Rodger brings 25+ years of experience as a senior architect, engineer, and managing consultant in the healthcare and life sciences industry specializing in big data and data science initiatives including enterprise data warehousing, AI and machine learning pipelines, cloud adoption, and advanced analytics such as identification / stratification, and predictive modeling.

Providing thought leadership, execution, and results in all engagements, he is a technologist with a propensity towards enabling organizations to remove barriers and thrive in a data driven ecosystem, including cloud adoption, distributed computing, big data, and data sciences. He has harnessed the power of digital petabytes into valuable usable & actionable collateral for the likes of WebMD, Blue Cross Blue Shield, and Alianz Life..

His passion is to develop transformative technologies in healthcare by staying on the cutting edge. He has been responsible for the development of healthcare solutions with tools such as the AWS Enterprise Data Hub Catalog (Lambda, S3, DynamoDB, Snowflake), Airflow HA, Terraform, Python, SQL, and Salesforce.

By merging compassion with data, Rodger is the digital backbone of our mission to save and improve lives with groundbreaking genetic technologies.

Jay has 30-year experience leading high growth healthcare services businesses. He has successfully led operating teams to double and triple the size of these businesses with the most recent one exceeding $1B revenues annually within 5 years through operational excellence and change acceleration.

He has expertise in leading globally distributed service delivery teams ranging from 150 to 2,500 associates. He has held senior executive leadership positions at both privately and publicly held companies such as GE Healthcare, Allscripts, Orion Health, and Aetna. Most recently, he served as Executive Vice President, Operations and Chief Transformation Officer at TRIMEDX.

Jay earned a master’s degree in Electrical Engineering from Alfred University and a bachelor’s degree in Electrical Engineering from Cornell University.

As a strong supporter of public service and US diplomacy, Mehmood has served in the executive branch of the US government as a senior advisor for strategy for our nation’s key international media networks. Previously he has been a partner in a residential real estate development fund, a private equity firm focused on SMEs in technology and healthcare management, and an international PE advisory firm focused on Turkey, MENA and SE Asia. As part of these roles, he has taken active management positions as an executive in companies in which his firms are invested or advising.

After completing his MBA from Harvard Business School, Mehmood spent five years at America Online as an operations strategy and marketing executive. At AOL, he managed over four- hundred million dollars of promotional inventory each year across America Online’s media network, and served as the business lead maximizing the impact and profitability of AOL’s famed ‘Welcome Screen’, then the highest-traffic page on the internet.

After completing his BA in Economics from George Washington University, as the recipient of a Presidential Honor Scholarship, Mehmood’s first business was launching, growing and eventually selling an international children’s educational media distribution and production company.

Mehmood is appointed to the Board of Visitors of George Mason University by the current Governor of Virginia and previously served on the Board of Virginia Tech by appointment of the prior Governor. He is a Fellow of UVA’s Sorensen Institute Political Leadership Program and has served two terms as a Member of the Consumer Protection Commission of Fairfax County, Virginia.

Justin Mars is a visionary in the recovery industry and an inspiring leader on our executive team. He has devoted his career to working with thousands of people in recovery. He is literally working to save lives every day, including mitigating suicide ideation as a Certified National Interventionalist with a QPR Suicide Prevention Master’s Training License. Mr. Mars receives fan mail regularly from clients and their families who thank him for saving their lives because they know how much he cares. He utilizes his 15 years of expertise in recovery, treatment, management, and leadership to set the standards of excellence in Symmetry.

He has managed a large network of treatment centers and is a leader in several recovery organizations. Mr. Mars has personally developed counseling, therapy, and community-based programs to improve lives for thousands of people suffering from substance abuse. He also provides business leadership and compliance advisory to recovery networks and organizations across California and the country. Mr. Mars attended University of Texas at Austin.

Oscar is an experienced financial executive with extensive and multi-faceted experience in IPOs and M&A. Oscar personally managed IPOs for 2 large companies, one of them a being a multi-billion dollar public offering. He started his early career at Accenture as a management consultant and got his first experience there, managing large teams and divisions. After this, he got his MBA from Harvard Business School and then started his career in finance at JP Morgan in investment banking. Following several years on Wall Street, he became the CFO for two public companies including Foresight Energy which had over $1 billion in revenue prior to its IPO that was managed by Oscar. Most recently, Oscar was the Chief Operating Officer of Equifax Workforce Solutions, which is a $1 billion division of Equifax where he led a team of 1,650 executives and employees successfully.

Oscar has spent most of his career playing C-level executive roles involved in driving the success of many large companies with an emphasis on financial planning and strategy. He has also worked around the world in multiple countries and has an international perspective in growing companies with a worldwide reach. Oscar comes to inGeneUs with the goal of expanding a company that can bring significant innovation to healthcare and help improve the lives of millions of people around the world.

Dr. Ali Raza is a physician entrepreneur that brings a unique skillset to inGeneUs as a result of his eclectic experience in engineering, finance, technology, and medicine. He started his college education at the age of 15, enrolling at Cornell University in electrical engineering and then receiving his master’s in electrical engineering from University of Pennsylvania. Dr. Raza started his career in corporate finance on Wall Street at JP Morgan and Credit Suisse for 7 years. He then shifted to development of technology business solutions for Pfizer and AOL. He shifted again as a pioneer of early telemedicine development in the late 1990s in New York City. Still not finding fulfillment, he ultimately decided to become a physician on the other side of the world at University of Sydney Medical School and a Fellow of the Royal College of General Practitioners. To put his medical degree to work, he built a premier integrative health care center in in Sydney, Australia called Ultimo Medical, to help improve the lives of thousands of patients.

After seeing the potential at inGeneUs and what his experience could bring to our company, Dr. Raza felt he could help build inGeneUs into a transformative healthcare company, so he moved back to the United States to achieve this objective while continuing to remotely advise and grow his medical team in Sydney. Through his diverse and circuitous journey, Dr. Raza has gained a range that is rare in healthcare. He has now emerged as a clinical pioneer for inGeneUs in merging integrative care with groundbreaking biomedical technology solutions for transformative change.

In addition to being one of the leading neurosurgeons of his generation, Dr. Sandhu was awarded Washingtonian Top Doctor for Neurosurgery in 2019 and is one of the strategic medical advisors in our company. Dr. Sandhu is an important advisor for the vision, groundbreaking research, and strategic growth of our company. He is a Professor of Neurological Surgery at Georgetown University Medical Center and Director of Spinal Surgery at Georgetown University Hospital. He owns several patents for his inventions in Neurological Surgery. Dr. Sandhu is recognized in Strathmore’s Who’s Who, Best Doctors, America’s Top Surgeons, and was awarded the Robert Kates Award for Outstanding Clinical and Research Work.

Dr. David Siwicki is a successful physician entrepreneur who founded two large national healthcare companies while also practicing as a board-certified physician in addiction medicine. He is an industry pioneer in diagnostic testing having founded two of the largest diagnostic testing companies in the country. He was a founder of Dominion Diagnostics and served as President and Director since its founding in 1997. Dominion Diagnostics is an accredited national medical laboratory that provides drug monitoring solutions and actionable clinical information to improve patient care and treatment outcomes in addiction medicine. He was also Founder and President of National WorkSafe, a national provider of medical review and drug testing verification services for the transportation industry. He has over 30 years of experience in healthcare as a physician and businessman.

Dr. Siwicki sits on the Herbert W. Boyer School of Natural Sciences, Mathematics, and Computing’s Advisory Council at Saint Vincent College in Latrobe, Pennsylvania. Dr. Siwicki also serves on the Executive Council of iEurope Capital, a Private Equity Firm investing in Central & Eastern Europe. From 1990 through 2010 he was a practicing member of Kent Emergency Physicians, Inc. Dr. Siwicki is Board Certified by the American Board of Addiction Medicine and is a certified Medical Review Officer.

Kareem Washington, PhD, is Chairman of the Department of Human Genetics at Howard University College of Medicine. An expert in molecular and applied genetics, Dr. Washington has worked with Dr. Mitchell to develop high-throughput screening (HTS) and ribonucleic acid (RNA) trans-splicing molecules (RTM) optimization procedures. Dr. Mitchell, a preeminent biochemical geneticist and professor, leads the Splice Therapeutics RTM core laboratory which creates and develops RTMs for the treatment of inherited and acquired genetic diseases.

Dr. Washington serves on the steering committee for the Center for Hemoglobin Research in Minorities at Howard University and is on the advisory board for the NIH National Human Research Genome Institute Atlas of Human Malformation Syndromes. He has published numerous articles and conference papers, including in the journals for Human Gene Therapy Methods, MDPI’s Biology, Anticancer Research, Molecular Therapy, Retrovirology, and Molecular and Cellular Biochemistry.

C. Anthony Altar, PhD, Splice Therapeutics founder, serves as COO and President. Dr. Altar is a 35-year biotech and pharma veteran with 135 publications in therapeutic gene and drug discovery. He led the Otsuka team that discovered Abilify, and with BMS, developed Abilify, the highest selling drug worldwide in 2014, with over $50B in sales. As CSO at Assurex Health, we created the most commercially successful and clinically-validated pharmacogenomic test, GeneSight, benefitting over 750,000 patients to date and supporting Assurex acquisition for $410M by Myriad Genetics. Other company experiences include Genentech, Regeneron, where he started the vision program and since 2016, with Verge Genomics, where, as CSO, Dr. Altar helped secure a $30M Series A round in 2018. 

C. Anthony Altar, PhD, Splice Therapeutics founder, serves as COO and President. Dr. Altar is a 35-year biotech and pharma veteran with 135 publications in therapeutic gene and drug discovery. He led the Otsuka team that discovered Abilify, and with BMS, developed Abilify, the highest selling drug worldwide in 2014, with over $50B in sales. As CSO at Assurex Health, we created the most commercially successful and clinically-validated pharmacogenomic test, GeneSight, benefitting over 750,000 patients to date and supporting Assurex acquisition for $410M by Myriad Genetics. Other company experiences include Genentech, Regeneron, where he started the vision program and since 2016, with Verge Genomics, where, as CSO, Dr. Altar helped secure a $30M Series A round in 2018. 

For 40 years, Dr. Mark S. Gold has conducted groundbreaking work in translational addiction research. Dr. Gold is a world leading physician, teacher, author, mentor, and inventor best known for his work on the brain systems underlying the effects of opioid drugs, cocaine, depression, and eating. As such, he serves as a Donald Dizney Eminent Scholar, Distinguished Professor, Chair of Psychiatry at the University of Florida College of Medicine, and member of the McKnight Brain Institute. He regularly lectures at medical schools, Grand Rounds and national scientific meetings on opioids, cocaine and the bench-to-bedside science in eating disorders, obesity, reward deficiency syndrome, and addictions. Dr. Gold co-authored the ground-breaking Food and Addiction by Oxford University Press and has published over 1000 peer-reviewed scientific articles, 20 textbooks, popular-general audience books, and physician practice guidelines.

Dr. Gold is an active member of the Clinical Council at the Washington University School of Medicine’s Public Health Institute. He has received numerous major national awards for his breakthrough research in Psychiatry including the annual Foundations Fund Prize (APA) for research in Psychiatry, the NAATP Lifetime Achievement Award, the American Foundation for Addiction Research’s Lifetime Achievement Award, the McGovern Award for Lifetime Achievement, and the 2019 Pillars of Excellence Lifetime Achievement Award. Dr. Gold was awarded the Distinguished Alumni Awards at Yale University, U.F., and Washington University and the Wall of Fame at the U.F. College of Medicine.  

For 40 years, Dr. Mark S. Gold has conducted groundbreaking work in translational addiction research. Dr. Gold is a world leading physician, teacher, author, mentor, and inventor best known for his work on the brain systems underlying the effects of opioid drugs, cocaine, depression, and eating. As such, he serves as a Donald Dizney Eminent Scholar, Distinguished Professor, Chair of Psychiatry at the University of Florida College of Medicine, and member of the McKnight Brain Institute. He regularly lectures at medical schools, Grand Rounds and national scientific meetings on opioids, cocaine and the bench-to-bedside science in eating disorders, obesity, reward deficiency syndrome, and addictions. Dr. Gold co-authored the ground-breaking Food and Addiction by Oxford University Press and has published over 1000 peer-reviewed scientific articles, 20 textbooks, popular-general audience books, and physician practice guidelines.

Dr. Gold is an active member of the Clinical Council at the Washington University School of Medicine’s Public Health Institute. He has received numerous major national awards for his breakthrough research in Psychiatry including the annual Foundations Fund Prize (APA) for research in Psychiatry, the NAATP Lifetime Achievement Award, the American Foundation for Addiction Research’s Lifetime Achievement Award, the McGovern Award for Lifetime Achievement, and the 2019 Pillars of Excellence Lifetime Achievement Award. Dr. Gold was awarded the Distinguished Alumni Awards at Yale University, U.F., and Washington University and the Wall of Fame at the U.F. College of Medicine.  

Lloyd G. Mitchell, MD, the sole inventor of RNA trans-splicing, is the founder, CEO and CSO of Splice Therapeutics. The prior venture he founded, Intronn, raised $10M in investments and $6M in U.S. National Institutes of Health (NIH) grants. Dr. Mitchell developed and patented RNA editing SMaRT™(Spliceosome Mediated RNA Trans-splicing) technology allowing for significant breakthroughs in disease and disorder management. SMaRT™ technology can reprogram the vast majority of human, plant and animal genes to correct genetic errors, confer a new function to a cell, or create novel gene products. Dr. Mitchell is a widely-recognized expert in molecular genetics, evidenced by 26 publications, including 15 on RNA trans-splicing and several early papers on the use of DNA sequencing for forensic identification, five active collaborations, and 13 issued US patents for trans-splicing reagents and applications. 

For over 15 years, he served as a senior staff fellow, Lt Commander, and guest researcher at the National Institute of Health. He has served as Associate Adjunct Professor at Howard University since 2013. With inGeneUs, Dr. Lloyd is applying this transformative technology to the behavioral health space, including addiction, depression, and anxiety.

Lloyd G. Mitchell, MD, the sole inventor of RNA trans-splicing, is the founder, CEO and CSO of Splice Therapeutics. The prior venture he founded, Intronn, raised $10M in investments and $6M in U.S. National Institutes of Health (NIH) grants. Dr. Mitchell developed and patented RNA editing SMaRT™(Spliceosome Mediated RNA Trans-splicing) technology allowing for significant breakthroughs in disease and disorder management. SMaRT™ technology can reprogram the vast majority of human, plant and animal genes to correct genetic errors, confer a new function to a cell, or create novel gene products. Dr. Mitchell is a widely-recognized expert in molecular genetics, evidenced by 26 publications, including 15 on RNA trans-splicing and several early papers on the use of DNA sequencing for forensic identification, five active collaborations, and 13 issued US patents for trans-splicing reagents and applications. 

For over 15 years, he served as a senior staff fellow, Lt Commander, and guest researcher at the National Institute of Health. He has served as Associate Adjunct Professor at Howard University since 2013. With inGeneUs, Dr. Lloyd is applying this transformative technology to the behavioral health space, including addiction, depression, and anxiety.

In addition to being one of the leading neurosurgeons of his generation, Dr. Sandhu was awarded Washingtonian Top Doctor for Neurosurgery in 2019 and is one of the strategic medical advisors in our company. Dr. Sandhu is an important advisor for the vision, groundbreaking research, and strategic growth of our company. He is a Professor of Neurological Surgery at Georgetown University Medical Center and Director of Spinal Surgery at Georgetown University Hospital. He owns several patents for his inventions in Neurological Surgery. Dr. Sandhu is recognized in Strathmore’s Who’s Who, Best Doctors, America’s Top Surgeons, and was awarded the Robert Kates Award for Outstanding Clinical and Research Work.

In addition to being one of the leading neurosurgeons of his generation, Dr. Sandhu was awarded Washingtonian Top Doctor for Neurosurgery in 2019 and is one of the strategic medical advisors in our company. Dr. Sandhu is an important advisor for the vision, groundbreaking research, and strategic growth of our company. He is a Professor of Neurological Surgery at Georgetown University Medical Center and Director of Spinal Surgery at Georgetown University Hospital. He owns several patents for his inventions in Neurological Surgery. Dr. Sandhu is recognized in Strathmore’s Who’s Who, Best Doctors, America’s Top Surgeons, and was awarded the Robert Kates Award for Outstanding Clinical and Research Work.

Kareem Washington, PhD, is Chairman of the Department of Human Genetics at Howard University College of Medicine. An expert in molecular and applied genetics, Dr. Washington has worked with Dr. Mitchell to develop high-throughput screening (HTS) and ribonucleic acid (RNA) trans-splicing molecules (RTM) optimization procedures. Dr. Mitchell, a preeminent biochemical geneticist and professor, leads the Splice Therapeutics RTM core laboratory which creates and develops RTMs for the treatment of inherited and acquired genetic diseases.

Dr. Washington serves on the steering committee for the Center for Hemoglobin Research in Minorities at Howard University and is on the advisory board for the NIH National Human Research Genome Institute Atlas of Human Malformation Syndromes. He has published numerous articles and conference papers, including in the journals for Human Gene Therapy Methods, MDPI’s Biology, Anticancer Research, Molecular Therapy, Retrovirology, and Molecular and Cellular Biochemistry.

Kareem Washington, PhD, is Chairman of the Department of Human Genetics at Howard University College of Medicine. An expert in molecular and applied genetics, Dr. Washington has worked with Dr. Mitchell to develop high-throughput screening (HTS) and ribonucleic acid (RNA) trans-splicing molecules (RTM) optimization procedures. Dr. Mitchell, a preeminent biochemical geneticist and professor, leads the Splice Therapeutics RTM core laboratory which creates and develops RTMs for the treatment of inherited and acquired genetic diseases.

Dr. Washington serves on the steering committee for the Center for Hemoglobin Research in Minorities at Howard University and is on the advisory board for the NIH National Human Research Genome Institute Atlas of Human Malformation Syndromes. He has published numerous articles and conference papers, including in the journals for Human Gene Therapy Methods, MDPI’s Biology, Anticancer Research, Molecular Therapy, Retrovirology, and Molecular and Cellular Biochemistry.

A trial lawyer, engineer, and founding partner of LA based Siddiqui LLP, Mr. Siddiqui focuses on trial advocacy and litigation in state and federal courts throughout the country. He is admitted to practice before the U.S. Supreme Court and has been selected as “Super Lawyer” seven years in a row from 2015 to 2021. Mr. Siddiqui also serves on the front lines of national defense as an advisor and consultant to the Federal Bureau of Investigation (FBI) on issues of national security and counter-terrorism and is an advisor and partner with the Central Intelligence Agency (CIA). For this work, Mr. Siddiqui has received numerous honors and awards from the CIA, the Department of Justice (DOJ), and the FBI, including the prestigious FBI Director’s Leadership Award presented by FBI Director James Comey in 2016. For his work as a first line of defense in national security matters, Mr. Siddiqui has worked with two US Presidents and leaders at the FBI and CIA. 

A powerful courtroom advocate, Mr. Siddiqui’s practice focus includes civil & business litigation, corporate law, intellectual property (copyrights ©, trademarks ®, patents), cyber law (computer, internet & e-commerce), and science & technology law. Mr. Siddiqui and his high-profile cases consistently appear in prominent media circuits on television and radio and in newspapers nationwide.

A trial lawyer, engineer, and founding partner of LA based Siddiqui LLP, Mr. Siddiqui focuses on trial advocacy and litigation in state and federal courts throughout the country. He is admitted to practice before the U.S. Supreme Court and has been selected as “Super Lawyer” seven years in a row from 2015 to 2021. Mr. Siddiqui also serves on the front lines of national defense as an advisor and consultant to the Federal Bureau of Investigation (FBI) on issues of national security and counter-terrorism and is an advisor and partner with the Central Intelligence Agency (CIA). For this work, Mr. Siddiqui has received numerous honors and awards from the CIA, the Department of Justice (DOJ), and the FBI, including the prestigious FBI Director’s Leadership Award presented by FBI Director James Comey in 2016. For his work as a first line of defense in national security matters, Mr. Siddiqui has worked with two US Presidents and leaders at the FBI and CIA.

A powerful courtroom advocate, Mr. Siddiqui’s practice focus includes civil & business litigation, corporate law, intellectual property (copyrights ©, trademarks ®, patents), cyber law (computer, internet & e-commerce), and science & technology law. Mr. Siddiqui and his high-profile cases consistently appear in prominent media circuits on television and radio and in newspapers nationwide.

For over two decades, attorney Harry Nelson has been on the front lines of behavioral health and medical advocacy, particularly relating to addiction recovery.  Mr. Nelson is the founder and managing partner of Nelson Hardiman, LLP, the largest healthcare and life sciences specialty law firm in Los Angeles.  He has been called “America’s #1 healthcare lawyer” and a “leading expert on our healthcare future”. His insights have earned the attention of lead policymakers and regulators at every federal agency touching the opioid crisis.  Mr. Nelson has been at the forefront of many next generation business technologies helping pave the way for innovation. In that realm, Mr. Nelson has been a legal and compliance advisor to our founder on three successful national start-up companies in healthcare (Imaging Advantage, Strategy Anesthesia, and inGeneUs).

Mr. Nelson won the Behavioral Health Network Resources 2018 Addiction Advocacy Award, he Chairs the Board of Behavioral Health Association of Providers, and he wrote the bestselling book, The United States of Opioids, A Prescription for Liberating a Nation in Pain (Forbes) which focuses on understanding the addiction crisis comprehensively and finding solutions to address the underlying drivers of US Healthcare. He sits on the boards of several healthcare organizations and is consulted regularly by federal and state executive agencies, legislators, and policymakers.

For over two decades, attorney Harry Nelson has been on the front lines of behavioral health and medical advocacy, particularly relating to addiction recovery.   Mr. Nelson is the founder and managing partner of Nelson Hardiman, LLP, the largest healthcare and life sciences specialty law firm in Los Angeles.  He has been called “America’s #1 healthcare lawyer” and a “leading expert on our healthcare future”. His insights have earned the attention of lead policymakers and regulators at every federal agency touching the opioid crisis.  Mr. Nelson has been at the forefront of many next generation business technologies helping pave the way for innovation. In that realm, Mr. Nelson has been a legal and compliance advisor to our founder on three successful national start-up companies in healthcare (Imaging Advantage, Strategy Anesthesia, and inGeneUs).

Mr. Nelson chairs the Board of Behavioral Health Association of Providers and won the Behavioral Health Network Resources Addiction Advocacy Award in 2018.  He has been recognized as one of the Best Lawyers in America annually from 2011 to 2021.  His bestselling book, The United States of Opioids,  A Prescription for Liberating a Nation in Pain (Forbes), received critical praise for changing the crisis-related conversation to discussion of comprehensive solutions.  Mr. Nelson continues to play a leading role in the expansion of telehealth and machine learning in medicine.

A best selling author, Mr. Collins is one of the nation’s most celebrated personalities in the men’s health and fitness arena with interviews and articles in the film “Bigger, Stronger, Faster” (2008) and on national television talk and news shows, talk radio interviews, and by countless online and print publications, including USA Today, ESPN.com, The New York Times, the Washington Post, the Los Angeles Times, MuscleMag, and the Huffington Post.

A best selling author, Mr. Collins is one of the nation’s most celebrated personalities in the men’s health and fitness arena with interviews and articles in the film “Bigger, Stronger, Faster” (2008) and on national television talk and news shows, talk radio interviews, and by countless online and print publications, including USA Today, ESPN.com, The New York Times, the Washington Post, the Los Angeles Times, MuscleMag, and the Huffington Post.